Market Update Economic Events Directors Deals Commodities Prices News Market Movers

ImmuPharma raises £2.7m fro share issue to Lanstead Capital

Wednesday, 26th June 2019
Specialist drug discovery and development company ImmuPharma said it had entered into a subscription agreement with Lanstead Capital Investors, raising around £2.7m.

New shares in the company were issued at 10p each, respresenting a 27% discount to their closing price on Tuesday.

The found would be used primarily for execution of the company's corporate strategy, ImmuPharma said.

At 2:23pm: (LON:IMM) ImmuPharma PLC share price was -1.64p at 11.96p

Story provided by

Related Shares: Immupharma

Share Search
Share Search Share Search

Visit the Share Search.
Share Search

Share News
Share News will do their best to ensure the quality of the information displayed on this site, but all information is provided as-is, free of charge. We cannot be held responsible for any loss, material or otherwise, due to incorrect information found here. UK data supplied by NBTrader and Digital Look. Share Prices are at least 15 minutes delayed.